Precision Oncology: DPYD and UGT1A1 Testing for Safer Chemotherapy in Real-World Practice
Speakers Dr. Erika Cecchin, PharmD, PhD Clinical Pharmacologist –Experimental and Clinical Pharmacology (ECP) Aviano National Cancer Institute (CRO), IRCCS (italy) “Personalizing Cancer Therapy Through Pharmacogenetics: DPYD, UGT1A1 and beyond” Dr. Stefania Tommasi Head – Unit of Molecular Diagnostics and Pharmacogenetics Giovanni Paolo II Cancer Institute, Bari (Italy) “Implementing DPYD and UGT1A1 Testing in Clinical Practice” […]